Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

ALDX Aldeyra Therapeutics Inc

4,89

0,00 (0,00%)

Vor Marktöffnung

Zuletzt aktualisiert: 10:07:43

Verzögert um 15 Minuten

Form 3 - Initial statement of beneficial ownership of securities

Aldeyra Therapeutics (NASDAQ:ALDX)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Aldeyra Therapeutics Charts.

Aldeyra Therapeutics (NASDAQ:ALDX)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Aldeyra Therapeutics Charts.

News Aldeyra Therapeutics Inc

Aldeyra Therapeutics to Participate in the Citi 2024 Global Healthcare Conference
Montag 2 Dezember 2024 (2 Monate vor) • Business Wire

Form 8-K - Current report
Montag 18 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Aldeyra Therapeutics Announces FDA Acceptance for Review of Reproxalap New Drug Application for the Treatment of Dry Eye Disease, Expands AbbVie Option Agreement
Montag 18 November 2024 (2 Monate vor) • Business Wire

Aldeyra Therapeutics to Participate in the Jefferies London Healthcare Conference
Donnerstag 14 November 2024 (2 Monate vor) • Business Wire

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 7 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Aldeyra Therapeutics Selected to Present at the Disruptive Innovations Symposium during the OSN New York Retina 2024 Meeting
Donnerstag 31 Oktober 2024 (3 Monate vor) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 22 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 3 Oktober 2024 (4 Monate vor) • Edgar (US Regulatory)

Aldeyra Therapeutics Resubmits Reproxalap New Drug Application for the Treatment of Dry Eye Disease
Donnerstag 3 Oktober 2024 (4 Monate vor) • Business Wire

Form 8-K - Current report
Mittwoch 2 Oktober 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Dienstag 10 September 2024 (4 Monate vor) • Edgar (US Regulatory)

Aldeyra Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
Donnerstag 5 September 2024 (5 Monate vor) • Business Wire

Weitere Aldeyra Therapeutics Inc News-Artikel

Synchrony Financiall

Aurelius Minerals

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen